Epinephrine automatic syringe, which is considerably cheaper than the episode of acute allergic reaction "epipen"

ByGreg Friese

"Epipen" used for emergency use when an acute allergic reaction has occurred has been rising from 100 dollars (about 15,000 yen) to 649.99 dollars (about 74,400 yen) in the last 6 years. In response to this, cheap substitutes have been sought, but CVS Health, the leading pharmaceutical manufacturer, has developed a product that is close to the price of conventional epipens, $ 109.99 (about 12,600 yen).

CVS Health Offers Patients Lowest Cash Price in the Market for Generic Epinephrine Auto-injector to Treat Allergic Reactions | CVS Health
https://cvshealth.com/newsroom/press-releases/cvs-health-offers-patients-lowest-cash-price-market-generic-epinephrine-auto


CVS just announced a super cheap generic alternative to EpiPen | Ars Technica
http://arstechnica.com/science/2017/01/cvs-just-announced-a-super-cheap-generic-alternative-to-epipen/

"Epipen" is a medicine from Mylan Pharma which improves shock symptoms with epinephrine (adrenaline) when an acute allergic reaction occurs, and epinephrine and injector (syringe) are set as a set.

Since the kit for injecting epinephrine has almost no replacement product, it is in the monopolistic state of Mylan Pharmaceutical, while the production cost has not changed, on the other hand the price is lifted, so it is big It is causing a rebound.

An acute allergy medicine "Epipen" Voice of anger in lifting price Photo 1 International News: AFPBB News
http://www.afpbb.com/articles/-/3098453


Because criticism is too strong, Mylan Pharmaceutical announced to release "Generic version Epipen" for $ 339.99 (about 38,800 yen).

Mylan, Allergic Drugs Half Price Launches for Late Releasing Price Received Criticism: Nihon Keizai Shimbun
http://www.nikkei.com/article/DGXLASGN29H0K_Q6A830C1000000/

The epinephrine injection kit announced by CVS Health this time is less than the current epipen, even the generic version Epipen is 109.99 dollars (about 12,600 yen). In addition, Teva Pharmaceutical is developing a similar epinephrine injection kit and is considered to be approved by the Food and Drug Administration (FDA) in 2018.

Teva says aims to launch EpiPen-like device by 2018 in U.S. | Reuters
http://www.reuters.com/article/us-teva-pharm-ind-epipen-idUSKCN11F25K